Tg Therapeutics (TGTX) Return on Sales (2016 - 2025)
Historic Return on Sales for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 2.42%.
- Tg Therapeutics' Return on Sales rose 23700.0% to 2.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84%, marking a year-over-year increase of 9000.0%. This contributed to the annual value of 0.07% for FY2024, which is 200.0% up from last year.
- As of Q3 2025, Tg Therapeutics' Return on Sales stood at 2.42%, which was up 23700.0% from 0.2% recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Return on Sales peaked at 2.42% during Q3 2025, and registered a low of 1005.01% during Q4 2022.
- Over the past 5 years, Tg Therapeutics' median Return on Sales value was 2.96% (recorded in 2023), while the average stood at 92.29%.
- As far as peak fluctuations go, Tg Therapeutics' Return on Sales skyrocketed by 22772000bps in 2021, and later crashed by -9645000bps in 2022.
- Tg Therapeutics' Return on Sales (Quarter) stood at 40.51% in 2021, then crashed by -2381bps to 1005.01% in 2022, then soared by 100bps to 0.33% in 2023, then skyrocketed by 166bps to 0.22% in 2024, then surged by 1020bps to 2.42% in 2025.
- Its Return on Sales was 2.42% in Q3 2025, compared to 0.2% in Q2 2025 and 0.04% in Q1 2025.